# Ocrelizumab Effects on the Metabolome in MS

> **NCT03873389** · — · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 25 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Ocrelizumab

## Key facts

- **NCT ID:** NCT03873389
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-12
- **Primary completion:** 2023-06-22
- **Final completion:** 2023-12-05
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03873389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03873389, "Ocrelizumab Effects on the Metabolome in MS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03873389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*